Orthofix International
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Orthofix International's revenues will contract -16.7% and EPS will increase 10.4%.
The average estimate for revenue is $120.5 million. On the bottom line, the average EPS estimate is $0.74.
Revenue details
Last quarter, Orthofix International logged revenue of $119.5 million. GAAP reported sales were 2.4% higher than the prior-year quarter's $116.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.78. GAAP EPS of $0.59 for Q2 were 9.3% higher than the prior-year quarter's $0.54 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 80.2%, 10 basis points better than the prior-year quarter. Operating margin was 18.7%, 70 basis points better than the prior-year quarter. Net margin was 9.4%, 90 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $491.9 million. The average EPS estimate is $3.05.
Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 119 members out of 127 rating the stock outperform, and eight members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 35 give Orthofix International a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Orthofix International is outperform, with an average price target of $47.67.
- Add Orthofix International to My Watchlist.